92 studies found for:    "Pneumonia, Bacterial"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia
Condition: Pneumonia, Bacterial
Intervention: Drug: daptomycin
2 Completed A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
Condition: Pneumonia, Bacterial
Interventions: Drug: Ceftriaxone;   Drug: beta-lactam
3 Terminated
Has Results
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia
Conditions: Pneumonia, Bacterial;   Community-Acquired Infections;   Nosocomial Infection;   Pneumonia, Ventilator-Associated
Interventions: Drug: Cefepime placebo;   Drug: Cefepime;   Drug: Doripenem;   Drug: Doripenem placebo;   Drug: Amoxicillin/clavulanate potassium
4 Recruiting Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
Conditions: Pneumonia, Bacterial;   Community-acquired
Interventions: Drug: Ceftaroline;   Drug: Levofloxacin
5 Recruiting Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
Condition: Pneumonia, Bacterial
Interventions: Drug: Amikacin fosfomycin inhalation solution;   Drug: Aerosolized placebo
6 Completed Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae
Condition: Pneumonia, Bacterial
Intervention: Drug: daptomycin
7 Terminated Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia
Condition: Community-Acquired Bacterial Pneumonia (CABP)
Interventions: Drug: JNJ-32729463;   Drug: moxifloxacin;   Drug: JNJ-32729463 (Open-Label)
8 Completed Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-Acquired Bacterial Pneumonia
Interventions: Drug: Levofloxacin;   Drug: CEM-101
9 Completed A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia
Conditions: Community-Acquired Bacterial Pneumonia;   Lung Infection of Individual Not Recently Hospitalized
Interventions: Drug: Ceftaroline;   Drug: Ceftriaxone
10 Recruiting Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-acquired Bacterial Pneumonia
Interventions: Drug: Solithromycin;   Drug: Moxifloxacin
11 Recruiting Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-acquired Bacterial Pneumonia
Interventions: Drug: Solithromycin;   Drug: Moxifloxacin
12 Withdrawn Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia
Condition: Community-Acquired Bacterial Pneumonia (CABP)
Intervention: Drug: Ceftaroline fosamil
13 Completed A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
Conditions: Pneumonia, Bacterial;   Nosocomial Infection;   Intraabdominal Infections;   Urinary Tract Infection
Intervention: Drug: No intervention
14 Completed Five Versus Seven Day Antibiotic Course for the Treatment of Pneumonia in the Intensive Care Unit
Condition: Pneumonia, Bacterial
Interventions: Other: 5 Days of Antibiotics;   Other: 7 Days of Antibiotics therapy for pneumonia
15 Not yet recruiting Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization
Condition: Pneumonia, Bacterial
Interventions: Drug: Amikacin Fosfomycin Inhalation Solution;   Drug: Aerosolized placebo
16 Recruiting Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013
Conditions: Pneumonia, Bacterial;   Pneumonia, Viral;   Meningitis, Bacterial
Intervention:
17 Not yet recruiting Efficacy, Safety, Tolerability of Carbavance Compared to Best Available Therapy in Serious Infections Due to Carbapenem Resistant Enterobacteriaceae, in Adults
Conditions: Urinary Tract Infection Complicated;   Acute Pyelonephritis;   Hospital Acquired Bacterial Pneumonia;   Ventilator-associated Bacterial Pneumonia;   Bacteremia
Interventions: Drug: Carbavance;   Drug: Best Available Therapy
18 Unknown  Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children
Conditions: Viral Pneumonia;   Bacterial Pneumonia
Intervention:
19 Completed
Has Results
The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)
Condition: Pneumonia, Bacterial
Intervention: Drug: ampicillin sodium/sulbactam sodium
20 Completed Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia
Condition: Community Acquired Bacterial Pneumonia
Intervention: Drug: Efficacy of ceftaroline

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years